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Framework conditions and requirements to ensure the
technicalfunctionalsafetyofreprocessedmedicaldevices
Rahmenbedingungen und Anforderungen zur Gewährleistung der
funktionell-technischen Sicherheit bei der Aufbereitung von
Medizinprodukten
Abstract
Testing and restoring technical-functional safety is an essential part of
medical device reprocessing. Technical functional tests have to be
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carried out on the medical device in the course of the validation of re-
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processing procedures. These ensure (in addition to the hygiene tests)
that the reprocessing procedure is suitable for the medical device.
Functional tests are, however, also a part of reprocessing procedures.
As a stage in the reprocessing, they ensure for the individual medical
device that no damage or other changes limit the performance.
When determining which technical-functional tests are to be carried
out, the current technological standard has to be taken into account in
the form of product-specific and process-oriented norms. Product-spe-
cific norms primarily define safety-relevant requirements. The risk
management method described in DIN EN ISO 14971 is the basis for
recognising hazards; the likelihood of such hazards arising can be
minimised through additional technical-functional tests, which may not
yet have been standardised. Risk management is part of a quality
managementsystem,whichmustbebindinglycertifiedformanufactur-
ers and processors of critical medical devices with particularly high
processing demands by a body accredited by the competent authority.
Keywords: functional safety of reprocessed medical devices, functional
testing, risk management, validation of reprocessing
Zusammenfassung
Die Prüfung und Wiederherstellung der technisch-funktionellen Sicher-
heit ist ein wesentlicher Bestandteil der Aufbereitung von Medizinpro-
dukten.ImRahmenderValidierungvonAufbereitungsverfahrenmüssen
technisch-funktionelle Prüfungen am Medizinprodukt erfolgen. Sie
stellen (neben den hygienischen Untersuchungen) sicher, dass der
Aufbereitungsprozess für das Medizinprodukt geeignet ist. Funktions-
prüfungensindjedochaucheinBestandteilvonAufbereitungsprozessen.
SiegewährleistenalsAufbereitungsschrittfürdaseinzelneMedizinpro-
dukt, dass keine Beschädigungen bzw. andere Veränderungen die
Leistungsfähigkeit einschränken.
BeiderFestlegungdurchzuführendertechnisch-funktionellerPrüfungen
ist der Stand der Technik in Form produktspezifischer und prozessori-
entierter Normen zu berücksichtigen. Produktspezifische Normen defi-
nieren vorrangig sicherheitsrelevante Anforderungen. Die in der Norm
DIN EN ISO 14971 beschriebenen Methodik des Risikomanagements
istdieGrundlagefürdasErkennenvonGefährdungen,derenAuftretens-
wahrscheinlichkeit durch ergänzende, bisher ggf. nicht genormte tech-
nisch-funktionelle Prüfungen verringert werden kann. Das Risikoma-
nagementistTeileinesQualitätsmanagementsystems,welchesverbind-
lich für Hersteller und Aufbereiter von kritischen Medizinprodukten mit
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Review Article OPEN ACCESSbesonders hohen Anforderungen an die Aufbereitung durch eine von
der zuständigen Behörde akkreditierte Stelle zertifiziert sein muss.
Schlüsselwörter:funktionelleSicherheitaufbereiteterMedizinprodukte,
funktionelle Prüfung, Risikomanagement, Validierung der Aufbereitung
Framework conditions and
requirements to ensure the
technical functional safety of
reprocessed medical devices
The term “reprocessing” is defined in § 3 para. 14 of the
German Medical Devices Act (Gesetz über Medizin-
produkte, hereinafter MPG) as follows: The reprocessing
of medical devices that, pursuant to their specifications,
are to be applied semi-sterile or sterile, is the cleaning,
disinfection and sterilisation (including the processes in-
volvedherein)aswellastheexaminationandrestoration
of technical-functional safety following their use, for the
purposes of repeated use.
Reprocessing encompasses cleaning, disinfection and
sterilisation,includingtheprocessesconnectedtherewith,
as well as the testing and restoration of technical-func-
tional safety. While the former processes aim to exclude
hygienicrisks,testingandrestoringthetechnicalfunction-
al safety guarantees the exclusion of hazards that could
arisefromalteredcharacteristicsofreprocessedmedical
devices. The German Ordinance on the Construction,
OperationandUseofMedicalDevices(Medizin-Produkte-
Betreiber-Verordnung, hereinafter MPBetreibV) provides
in § 4 ‘Maintenance’ that: “The reprocessing of medical
devicesthat,accordingtotheirpurpose,aretobeapplied
semi-sterile or sterile, is to be carried out taking into ac-
count the manufacturer’s specifications using a suitable
validatedprocedure,sothatthesuccessofthisprocedure
can be verifiably ensured and the safety and health of
patients,operatorsorthirdpartiesisnotputatrisk”.This
requirement also refers indirectly to technical tests, be-
cause the success of the procedure, or, as the case may
be, the exclusion of hazards connected therewith, can
only be verifiably proven if, in addition to hygienic safety
tests, the functional and application characteristics of
reprocessed medical devices are also tested. Medical
devicesmustfulfiltheirpurposewithoutlimitationduring
each use, regardless of how many times they are used.
In order to comply with the basic principle of the free
movement of goods, services and capital, the Member
States of the European Community also issued various
directives on medical devices. The “basic requirements
for medical devices” are set forth in Annex I to Directive
93/42/EECconcerningmedicaldevices.Theseprovisions
were transposed into German national statutory provi-
sionswithoutalteration(MPG§7‘BasicRequirements’).
The directive 93/42/EEC is not applicable for: active im-
plantable medical devices (90/385/EEC), in-vitro-diag-
nostics (98/79/EEC) and medical devices that contain
stable derivatives of human blood or blood plasma
(2000/07/EEC).
Several of the requirements set forth in Directive
93/42/EEC [3] relate to medical devices intended by the
manufacturer to be used repeatedly. Accordingly, Art.
13.6 of Annex I requires that the directions for use state
“details concerning suitable processing procedures, e.g.
cleaning, disinfection, packaging and, where applicable,
sterilisation procedures … as well as information on any
limit to the number of times it can be reused …”, thereby
placing the responsibility for the selection and suitability
ofthereprocessingproceduresfortheseproducts(includ-
ing the requisite technical-functional tests) on the manu-
facturer.Inadditiontothesemedicaldevicesandmedical
devices which are not suitable for reprocessing due to,
for example, their construction, on technical, material
grounds or on the basis of hygiene-related or ethical
reasons, there is also a group of products for which the
manufacturers do not state any reprocessing procedure,
but for which it has been proven that they can be repro-
cessed with suitable procedures that can be validated
(pursuant to § 4 MPBetreibV).
Despite the fact that, to date, Directive 93/42/EEC does
not contain any stipulations specifically governing these
medical devices (national interests and statutory frame-
workconditionsoftheMemberStatesvaryconsiderably),
the ‘basic requirements’ also apply to them. Thus, Art. 3
of Annex I requires that: “The devices must achieve the
performances intended by the manufacturer…” This ap-
plies for each use of a medical device, regardless of the
number of completed applications or the issue of initial
market authorisation. The conformity of a reprocessed
medical device with the basic requirements may not be
altered, even if a new conformity assessment procedure
is not necessary, provided there is no new incidence of
theproductbeingplacedonthemarket.Theachievement
of the “intended performance” is ensured if the medical
devicefulfilsitsintendedusewithoutlimitationsinterms
of the stated quality and required safety for the patient,
for the user or for third parties. In the case of medical
devices that the manufacturer does not intend to be re-
used, the suitability of a reprocessing procedure (which
canbevalidated)isgivenonlyifthefunctionalitycanalso
beprovenintermsoftechnical-functionaltests.Thecosts
ofthetestsnecessaryinthisconnectioncanvarygreatly.
Which tests are necessary depends inter alia on the
complexityofthemedicaldevice,thestyleofconstruction,
the rawmaterialsused,the areaof application,thedura-
tion of the application, the reprocessing procedure and
– perhaps most importantly – on the risk potential of the
medical device, and must (as explained below) be deter-
mined according to the individual product in the course
of the development and validation of a reprocessing
procedure.
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(MPBetreibV) proper reprocessing is assumed, “if the
joint recommendation of the Commission for Hospital
Hygiene and the Prevention of Infection at the Robert
Koch Institute (RKI) and the Federal Institute for Drugs
and Medical Devices (BfArM) concerning the hygiene re-
quirementswhenprocessingmedicaldevicesisobserved”
[1]. This guideline recommends that the validation of a
reprocessing procedure should be proportionate to the
medical device, to “the risk evaluation and categorisa-
tion”, and should be carried out “in accordance with the
accepted rules of technology, taking into account the
current scientific and technological standards”. The
design parameters of the medical device to ensure the
technical-functional safety (suitability of the procedure
for the medical device) “that are necessary to prove that
the process in question (individual stage of processing)
is carried out in a form that guarantees the attainment
of the specifications defined in each case”, are also
stated,inadditiontotheparametersforensuring“effect-
ivecleaning,disinfectionandsterilisation”.Thus,technic-
al-functional tests must also be carried out in the course
of the validation of reprocessing procedures. These en-
sure (in addition to the hygiene tests) that the repro-
cessing procedure is suitable for the medical device.
These technical-functional tests in the course of the val-
idation of reprocessing procedures are usually carried
outintheformofrandomtests,suchthatcharacteristics
critical for the success of reprocessed medical devices
can be compared with the corresponding parameters of
new products. The product characteristics to be tested
are selected, as explained below, as part of the risk
management.
Furthermore,theaforementionedRKIandBfArMguideline
[1] also stipulates the individual reprocessing stages. In
addition to cleaning/disinfection, rinsing and drying, and
otheradditionalsteps,thisusuallyalsoincludesfunction-
al tests. These exclude the possibility for the individual
medical device that damage or, as the case may be,
other changes, limit the functionality, although proof of
the theoretical suitability of the procedure used was
already provided in the course of the validation of the
reprocessing procedure. This is necessary because indi-
vidual or coincidental effects (e.g. when the device is
used incorrectly or the necessary transport conditions
arenotobserved)canalsoconstitutehazardswhenusing
reprocessed medical devices and, consequently, the af-
fected products cannot be used again. In this regard, the
RKI and BfArM guideline [1] states: “The objective of the
tests on … defined technical-functional characteristics is
tosortoutmedicaldevicesinwhich…technical-functional
defects cannot be removed.” The scope and the cost of
the functional tests that constitute part of the repro-
cessingprocedureisoftenlowerthanthatofthefunction-
al tests that are relevant to the validation. This is due to
the option of being able to limit these tests to those
productattributesthatarerelevanttothesafetyandthat
can be affected by individual or coincidental effects.
These tests are usually carried out after cleaning/disin-
fection, rinsing and drying, in order to be able to record
anypossiblenegativeeffectsofthesereprocessingstages
on the medical device as well. In the case of medical
devices to be applied semi-sterile or sterile, however, re-
contamination through the test substances must be ex-
cluded. The RKI and BfArM guideline [1] requires that:
“contamination with harmful substances (e.g. toxic
cleaning materials) or particles (e.g. talcum) that outlive
the following stages of reprocessing may not occur.”
When determining or selecting the necessary functional
tests to be carried out on reprocessed medical devices,
themanufacturerorprocessor,asexplainedabove,must
takeintoaccountthecurrentscientificandtechnological
standards. Studies with the highest possible level of
evidence and recognised publications substantiate the
current scientific standard. The current technological
standardisdocumentedmainlythroughnormsandrecog-
nised standards. Accordingly, § 8 para. 1 of the Medical
DevicesAct(MPG)states:“ifmedicaldevicescomplywith
harmonised norms or equivalent monographies of the
European Pharmacopoeia or Joint Technical Specifica-
tions that apply to the medical device in question, it shall
to this extent be assumed that these comply with the
provisionsofthisAct.”Bothproduct-specificandprocess-
oriented norms are relevant, in particular with regard to
quality management and risk management, as well as
theproceduresappliedinthereprocessing(amongothers
cleaning, disinfection, sterilisation, electrical, biological
testswhichcontainsadetailedlistofrelevantnorms[2]).
Product-specificnormsprimarilydefinerequirementsthat
are relevant to safety. For example, ISO 10555-4 [3]
specifiesforballooncatheters:testsofthesurfacefinish,
resistance to corrosion, tensile strength, leakage rate, x-
ray visibility, surface structure and resistance to bursting
ofthecatheterballoon(fatigue).Thesetestsarerelevant
tothesafetyand,asaresult,aretobetakenintoaccount
inthecourseofthevalidationofthereprocessingproced-
ure carried out on medical devices. However, they are
informative only to a very limited extent with regard to
the characteristics of the product in question that are
relevanttoitsapplicationand,evenwherealltestrequire-
ments are met, they do not allow any conclusions to be
drawn as to the degree of suitability of a medical device
foritsapplication(e.g.forballooncathetersthesuitability
of the balloon for relief of vaco-constriction). Con-
sequently, additional functional tests may have to be
carried out. As the balloon catheter example clarifies,
these tests are, for example, tests on the internal-pres-
sure-dependent diameter of the balloon as well as the
inflation and deflation times. Although these kinds of
tests are not standardised for balloon catheters, these
are parameters that are critical to success and it is obvi-
ous that these have to be tested in order to exclude any
hazards. The RKI and BfArM also state in their guideline
[1] that effects of the reprocessing procedure on the
material characteristics and on the technical-functional
safety are, as a rule, product-specific and therefore have
to be examined in each individual case.
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devicemust,intheinterestsoffullandsystematicrecord-
ing, be developed using the method described in DIN EN
ISO 149715 [4]. The risk management outlined in this
norm encompasses the analysis, the evaluation and the
control of the risk initially ascertained by way of risk-re-
duction measures, as well as the re-evaluation, following
completion of these measures. Risk analyses are also
part of the technical documentation for medical devices
and are important for the declaration of conformity and
the CE-mark when fulfilling the basic requirements for
placing new products on the market.
The first stage in risk management pursuant to DIN EN
ISO14971[6]isthehazardanalysis,inwhichallpotential
sources of harm, which may arise both in the case of
proper and improper use of the medical device, are as-
certained. Every function of the medical device is ex-
amined in terms of reasonably expected consequences
of events that could lead to harm for the most diverse
usesituations.Foreachascertainedhazard,theriskmust
bedeterminedbyestimatingthelikelihoodofitoccurring
and the potential extent of the damage. Among others,
therisksnamedintheRKIandBfArMguideline[1],which
can arise through
• residues from the preceding application (e.g. blood,
blood components, secretions and other bodily com-
ponents, other medicinal products),
• residues from the preceding processing procedure
(e.g. substances used in cleaning, disinfection, and
sterilisation,aswellasothermaterials,includingreac-
tion products thereof),
• changes to the physical, chemical or functional char-
acteristics of the medical device or
• changes to the condition of the material (e.g. acceler-
ated wearing of the material, embrittlement and
altered surface characteristics, changes to contact
points and adhesive bonding).
are to be taken into account.
Usually,theascertainedriskisallocatedtoaclassofrisk.
Acceptable risks can, compared with the benefits, be
disregarded. Unacceptable risks are so serious that a
system involving these risks would be untenable. They
must be reduced by limiting the extent of the damage
and/or the likelihood of the hazard occurring. The latter
can be achieved, for example, through tests that reveal
negative divergent product characteristics. Necessary
tests,whichhavenotyetbeenstandardised(standardised
testsdocument,asexplainedabove,thecurrenttechnical
standard and are in any case relevant), are therefore
specifiedasriskreductionmeasuresinthecourseofrisk
management.
However, it is not possible to estimate for every medical
device used over a longer period of time, the damage
caused by, or the likelihood of all potential events that
may shorten its lifespan on the basis of theoretical ana-
lysis. This is why, in specific cases, these are to be under-
pinned by relatively expensive mechanical tests, which
effect “artificial ageing” in terms of simulated use and
processing and provide statistically representative proof
that it is possible to use the medical device repeatedly,
without technical-functional limitations. Precise know-
ledge of the operational demands that are typical of the
usage is necessary in order to carry out tests of this kind.
It is also important that the tests are carried out on new
products (without prior damages). The scope of the ran-
dom tests should be as broad as possible, because then
the coincidental differences between the results of the
random test and the actual conditions in the target
population are smaller. Subject to known or expected
marginalconditions(standarddivergence,selectivityand
expected relative difference) the size of the random test,
which is dependent on the test procedure, can be calcu-
lated.
Risk management is part of a quality management sys-
tem, which must be bindingly certified for manufacturers
andprocessorsofcriticalmedicaldeviceswithparticularly
high processing demands by a body accredited by the
competent authority pursuant to DIN EN ISO13485 [5]
(see [1]). The base for the risk management is the classi-
ficationpursuanttotherecommendationoftheCommis-
sion for Hospital Hygiene and the prevention of Infection
attheRobertKoch-Institute(RKI)andtheFederalInstitute
for Medicinal Products and medical devices (BfArM) re-
garding the hygiene requirements when processing
medical devices [1].
Thereproducibilityoftheresultsoftheprocessingneces-
sary for validation can only be attained through the
compliance with and constant monitoring of all process
parameters in the processing stages. This is the only way
thattheproofofthetheoreticalsuitabilityofaprocessing
procedureestablishedbywayoftechnical-functionaltests
and other tests for a medical device can be transferred
toallsubsequentapplicationsoftheprocedure.Reprodu-
cible process parameters are ensured when using
cleaning/disinfectionequipmentbywayofcorresponding
process monitoring (see DIN EN ISO 15883 washing and
disinfection of instruments), while manual procedures
always entail greater risks. The RKI and BfArM guideline
[1]statesinthisconnection:“inmechanicalcleaningand
disinfection procedures it can be ensured in terms of the
processthattheparametersnecessarytoattainquantifi-
able cleaning and disinfection performance, e.g. water
volume, water pressure, temperature, pH-level, dosage
ofcleaninganddisinfectionsubstancesandcontacttime,
are observed. The machines’ monitoring, control and
warning systems constitute the prerequisite for secure
cleaning and disinfection and, thus, reprocessing”. Pur-
suanttotheclassificationofmedicaldevicesonthebasis
oftheirhazardpotential,whichissetforthintheguideline
[1], mechanical cleaning and disinfection is already the
preferred method for semi-critical medical devices with
morestringentrequirementsintermsofthereprocessing
(e.g.gastroscopes)andforcriticalmedicaldeviceswithout
special requirements in terms of the reprocessing (e.g.
wound retractors). For critical medical devices with more
stringent processing requirements (e.g. MIS trocars)
mechanicalcleaninganddisinfectionisgenerallyrequired
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icaldeviceswithparticularlystringentprocessingrequire-
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